Clinical significance of changes in the Th17/Treg ratio in autoimmune liver disease

Table 2 On-admission liver function of the patients with different outcomes in group EA

Liver function	Unhealed group (n = 12)	Improved group (n = 19)	P value
TBIL (μmol/L)	166.75 (112.70, 244.30)	103.10 (46.90, 175.20)	0.114
DBIL (μmol/L)	122.0 (80.20, 122.00)	70.30 (28.80, 121.00)	0.059
ALT (U/L)	57.50 (44.00, 106.50)	195.00 (104.00, 724.00)	0.002
AST (U/L)	86.00 (53.50, 94.75)	151.00 (103.00, 513.00)	0.001
ALP (U/L)	153.00 (115.00, 405.00)	121.50 (95.50, 151.25)	0.089
γGGT (U/L)	259.00 (144.50, 370.00)	133.00 (69.75, 253.50)	0.072
GLB (g/L)	30.16 ± 6.27	29.48 ± 5.42	0.756

TBIL: Total bilirubin; DBIL: Direct bilirubin; ALT: Glutamic-pyruvic transaminase; AST: Glutamic-oxaloacetic transaminase; ALP: Alkaline phosphatase; γ-GT: γ-glutamyl transferase.